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Abstract  42 
Childhood obesity predicts the risk of adult adiposity, which is associated with the 43 
earlier onset of cardiovascular disease [adult atherosclerotic cardiovascular disease, 44 
ACVD: hypertension, increased carotid intima media thickness (CIMT) stroke, 45 
ischemic heart disease (IHD)] and dysglycemia. Because it is not known whether 46 
childhood obesity contributes to these diseases, we conducted a systematic review of 47 
studies that examine the ability of measures of obesity in childhood to predict 48 
dysglycemia and ACVD. 49 
Data sources were: Web of Science, MEDLINE, PubMed, CINAHL, Cochrane, 50 
SCOPUS, ProQuest, and reference lists. Studies measuring BMI, SF, and WC were 51 
selected; of 1954 studies, 18 met study criteria. 52 
Results: Childhood BMI predicted CIMT: OR, 3.39 (95% CI, 2.02 to 5.67, P <0.001) 53 
and risk of impaired glucose tolerance in adulthood, but its ability to predict ACVD 54 
events (stroke, IHD; OR, 1.04; 95% CI, 1.02 to 1.07; P<0.001) and hypertension (OR, 55 
1.17, 95% CI 1.06 to 1.27, P = 0.003), was weak-moderate. BMI was not predictive 56 
of systolic BP (r -0.57, P =0.08) and weakly predicted diastolic BP (r 0.21, P =0.002). 57 
SF in childhood weakly predicted CIMT in female adults only (rs0.09, P <0.05).  58 
Conclusion: Childhood BMI predicts the risk of dysglycemia and abnormal CIMT in 59 
adulthood but its ability to predict hypertension and ACVD events was weak and 60 
moderate respectively. SF was a weak predictor of CIMT in female adults. 61 
 62 
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INTRODUCTION 70 
Obesity has become increasingly prevalent worldwide in both children and adults 
1,2
.  71 
It is detected by specific cut-offs in anthropometric measures - the most popular of 72 
which is the body mass index (BMI) 
3,4
. Although used less often in clinical practice, 73 
measures of adiposity such as waist circumference (WC) and skin fold thickness (SF) 74 
are thought to be more predictive of adiposity-related comorbid conditions - perhaps 75 
because they more closely correlate with the presence of excess body fat 
5,6
 76 
Irrespective of how it is measured, adult obesity is associated with dysglycemia and 77 
an increased incidence of atherosclerotic cardiovascular disease (ACVD) and type 2 78 
diabetes (T2D) 
1, 7
,
 
which together are responsible for over half of all deaths from 79 
non-communicable diseases worldwide 
8
. Although the relationship between adult 80 
obesity and ACVD risk factors is convincing 
9
, the association of anthropometric 81 
measures of obesity in childhood with disease in adulthood remains uncertain
10
. This 82 
is despite the fact that increased adiposity in childhood is predictive of overweight 83 
adults
11
, and that ACVD risk factors are more prevalent in obese children than those 84 
of normal weight 
12, 13
. The predictive ability of anthropometry in childhood 
19, 20
 may 85 
relate to the method used to determine obesity. For instance, in children, BMI 86 
explains just 40% of the variance in insulin resistance 
14,15
, whereas WC appears more 87 
predictive of insulin resistance and dyslipidaemia 
16,17
. SF has been reported to 88 
increase the sensitivity of WC to detect dysglycemia by up to 15% 
18
.  To investigate 89 
this, we systematically reviewed and pooled data from longitudinal studies that 90 
examined the association between anthropometric measures of childhood adiposity 91 
and adult ACVD, prediabetes and type 2 diabetes. 92 
 93 
 94 
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METHODS 95 
 96 
We conducted a systematic review and meta-analysis of longitudinal cohort studies of 97 
anthropometric measures of obesity (Body Mass Index-BMI, skinfold thickness-SF, 98 
and waist circumference-WC) in childhood and the relationship to the risk of ACVD 99 
and dysglycemia in adulthood. We followed the Meta-analysis of Observational 100 
Studies in Epidemiology guidelines for meta-analyses and systematic reviews of 101 
observational studies (MOOSE)
21
.  102 
Search Strategy  103 
We used a systematic approach for searching the literature with specific eligibility 104 
criteria. We searched 7 electronic databases: Web of Science, MEDLINE, PubMed, 105 
CINAHL, Cochrane, SCOPUS and ProQuest from inception through September 2014 106 
to identify appropriate literature. We also searched the bibliographies of the included 107 
studies to identify any other relevant articles. Our search strategy utilized medical 108 
subject headings (MeSH)/ index terms across databases including the terms: BMI, 109 
change in BMI, skinfold, waist circumference, cerebrovascular disease, stroke, 110 
hypertension, ischemic heart disease, coronary artery disease, vascular dysfunction, 111 
carotid intima media thickness, dysglycemia, impaired fasting glucose, impaired 112 
glucose tolerance, type 2 diabetes, adult, and child. The full search strategy is 113 
provided in the supplemental data and on the international prospective register of 114 
systematic reviews (PROSPERO, registration number CRD42014014392).  115 
Study selection (figure 1) 116 
All relevant abstracts were downloaded into an online reference management system 117 
(RefWorks; ProQuest LLC). Using a screening tool, two reviewers (O.A, C.B.) 118 
independently evaluated and screened all citations and abstracts for eligibility. Studies 119 
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included were longitudinal studies of healthy children recruited between 2 and 18 120 
years of age, where BMI, change in BMI, SF or WC were used as predictors of blood 121 
pressure, ACVD (carotid intima media thickness, hypertension or events including 122 
cerebrovascular disease/stroke ischemic heart disease or vascular dysfunction) or 123 
dysglycemia (impaired fasting glucose, impaired glucose tolerance or T2D) in 124 
adulthood (defined as ≥ 18 years). Although not considered direct measures of 125 
adiposity, because of the link between pubertal timing and obesity 
22
, studies of peak 126 
height and weight velocity were included. No limits were placed on the searches in 127 
terms of sample size, duration of follow-up, region/country/language of publication. 128 
Studies were excluded if the participants were part of an intervention program, if 129 
outcomes were self-reported, if anthropometric measures were classified using 130 
arbitrary cut-off points, or if children with a diagnosis of malignancy, diabetes, 131 
hypertension, preterm birth or low birth weight were included. A third reviewer 132 
compared the entered data and resolved inconsistencies by referring to the full text 133 
article (M.W.). 134 
Data extraction 135 
For each study we extracted baseline characteristics of the participants (age, gender 136 
and birth cohort) and study characteristics (location, length of follow-up, 137 
anthropometric measure [BMI, SF, PHV, PWV, and WC] and outcome measure). 138 
Data were directly extracted from the article or from figures. Multiple attempts were 139 
made to contact authors in order to obtain for data missing from published results.  140 
Study Quality Assessment 141 
Study quality was assessed using the Newcastle-Ottawa Scale (NOS) 
23
 for cohort 142 
studies.  This scale assigns ‘star ratings’ based on several criteria including:  143 
Page 6 of 33Obesity Reviews
  
• The representativeness of the study population compared to the community 144 
average 145 
• Demonstration that the outcome of interest was not present at the start of the 146 
study,  147 
• How the outcome was assessed, and  148 
• Whether follow-up was of sufficient duration for outcomes to occur. 149 
Statistical Analysis 150 
The data analysis was performed using the Mantel-Haenszel method by meta-analysis 151 
software ‘Comprehensive Meta-Analysis 2.0’ (Biostat, Englewood, NJ, United 152 
States). For each study, we calculated the odds ratio (OR) or means for the primary 153 
outcome measure of adiposity. The ORs and means were presented with 95% 154 
confidence intervals (CIs), with a P-value < 0.05 considered significant. We estimated 155 
the degree of heterogeneity among the trial results using the χ
2
 statistic (with a P-156 
value < 0.10 considered significant) and the I
2
 test (25%, 50%, and 75% represent 157 
low, moderate and high heterogeneity, respectively). Whenever significant 158 
heterogeneity (P < 0.1 or I
2
 > 50%) was detected, we used the random effects model 159 
to combine the effect sizes of included studies; otherwise, the fixed effects model was 160 
utilized. Subgroup analyses were performed for systolic and diastolic blood pressure, 161 
but not for those investigating peak height and weight velocity to avoid data dredging; 162 
more so there were no other studies found with similar outcomes making it impossible 163 
to conduct further quantitative analysis of these studies. We assessed the presence of 164 
publication bias with a funnel plot of standard error by log odds ratio (see Figure 1). 165 
Large studies appear at the top of the graph and cluster near the mean effect size. The 166 
absence of significant publication bias is indicated by a symmetrical distribution 167 
around the combined effect size.  168 
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RESULTS AND DISCUSSION 169 
The search identified 1954 citations (1934 from database searches and 20 from 170 
reference lists) from which 18 studies were found relevant to this review. The 171 
selection process has been represented using a PRISMA flow diagram (Figure 2) 172 
Most of the studies were conducted in industrialized countries: six in North America 173 
24-29
, five in Finland 
30-34
, four in the United Kingdom 
35-38
, one each in India 
39
, 174 
Denmark 
40
, and The Netherlands 
41
. Of the total of 317,133 adults studied, the 175 
majority were white Caucasian. The mean age at which baseline childhood data was 176 
collected was 10y, and mean follow-up was 25 years. Table 1 shows the 177 
characteristics of each study; Five studies were excluded from the meta-analysis 178 
because the method of statistical analysis (rank correlation coefficients which cannot 179 
be converted to odds ratio) precluded inclusion 
26
, the study subjects were classified 180 
based on BMI category/glycemic function in childhood 
24, 30, 33
, or because there were 181 
insufficient studies within a subgroup for adequate comparison 
33
. As further analysis 182 
of these studies could not be undertaken, a qualitative summary of the results was 183 
prepared; these studies were not included in any statistical analyses.  184 
 185 
Childhood predictors for adult atherosclerotic cardiovascular disease and/or 186 
dysglycaemia  187 
Studies used one or more of the following: BMI, standardized BMI scores, change in 188 
BMI, SF, or combination of BMI and skin folds (SF)
 28 
as childhood predictors, with 189 
the exception of Tzoulaki et al 
33
 in which peak height velocity (PHV) and peak 190 
weight velocity (PWV) were used as childhood predictors.  191 
 192 
 193 
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Outcome measures 194 
Seven studies assessed the presence of ACVD by carotid intima media thickness 195 
(CIMT) 
26,28,29 31,32, 38, 41 
, three studied the incidence of ACVD events 
34, 36, 40
, while 196 
five examined blood pressure (BP) or the presence of hypertension 
25, 27, 33, 35, 37
. 197 
Hypertension was defined as at least one of the following: prescription for blood 198 
pressure lowering medication, systolic BP (SBP) ≥140 mmHg, and diastolic BP 199 
(DBP) ≥90 mmHg. Of the three studies that investigated the incidence of dysglycemia 200 
24, 33, 39
, two used both impaired glucose tolerance (IGT) and T2D 
24, 39
 and one 201 
studied the association with T2D alone 
33
. IGT and T2D were defined by either the 202 
American Diabetes Association (ADA; 1997) 
24, 33
 or the WHO (1998) 
39
 criteria. 203 
Study Quality and Publication Bias 204 
Study quality was assessed using appropriate elements of the Newcastle-Ottawa scale 205 
23 
(Table 2). All the studies scored at least four ‘stars’ out of a possible six indicating 206 
good methodological quality. We assessed the presence of publication bias with a 207 
funnel plot of standard error by log odds ratio (Figure 1). The absence of significant 208 
publication bias is indicated by a symmetrical distribution around the combined effect 209 
size. 210 
Meta-analysis 211 
Figure 3 provides the forest plot with pooled estimates and 95% CI values for the 212 
ability of childhood BMI to predict outcomes (detailed below). Table 3 provides the 213 
relative weight of each study.  214 
 215 
BMI/SF and CIMT 216 
Childhood BMI was predictive of CIMT in adulthood (OR, 3.5; 95% CI, 1.1 – 11.1, P 217 
= 0.034) even after adjusting for adult BMI. With the variability across the studies 218 
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exceeding what would be expected based purely on sampling error (I
2
 98.9%, n=6 219 
studies), random effects analysis was conducted. Two studies were not included in the 220 
quantitative analysis because the statistical method of analysis used was not 221 
compatible for meta-analysis 
26 27
. Field et al 
27
 found that a 1- standard deviation 222 
increase in SF in childhood was associated with 16 µm increase in CIMT in adulthood 223 
while Davis et al 
26 
found very weak correlations between BMI/SF in childhood and 224 
adult CIMT in females (BMI: spearman rank correlation  0.18, P <0.001, SF  225 
0.09, P <0.05).   226 
BMI and AVCD events 227 
Childhood BMI had a negligible ability to predict the development of ACVD events 228 
in adulthood, (OR, 1.04; 95% CI, 1.02 to 1.07; P<0.001). None of the studies 229 
however, made statistical adjustment for the effect of BMI in adulthood. The 230 
variability across the studies did not exceed what would be expected based on 231 
sampling error (I
2 
11.2%, n=3 studies). 232 
BMI, blood pressure and hypertension 233 
After statistical adjustments were made for the impact of adult BMI, childhood BMI 234 
was weakly predictive of adult diastolic blood pressure (mean, 0.25; 95% CI, 0.003 to 235 
0.386; P=0.046) but not systolic blood pressure (mean, -0.57, 95% CI, -1.22 to 0.07; 236 
P=0.082). Due to the presence of moderate variability across the studies for diastolic 237 
pressure (I
2
 53%), random effects analysis was conducted. BMI in childhood 238 
predicted the risk of adult hypertension (OR, 1.17, 95% CI 1.06 to 1.27, P = 0.003) 
35, 
239 
40
, while Tzoulaki et al 
33
 found no relationship between peak weight velocity in 240 
childhood and adult hypertension. 241 
BMI and dysglycemia  242 
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Nguyen et al 
24
 found that neither BMI nor childhood weight gain predicted the risk 243 
of adult diabetes. However the odds ratios of developing prediabetes in adulthood 244 
using baseline BMI and change in BMI in childhood were 1.44 and 1.85 respectively. 245 
By contrast, the odds ratios of adult prediabetes for those at the top decile for fasting 246 
insulin and HOMA-IR (insulin resistance) in childhood were 2.85 and 2.55 247 
respectively. Conversely, Fall et al 
39
 found that those who gained weight in 248 
childhood were more likely to develop IGT/T2D in adulthood (regression coefficient 249 
1.25, P=0.01) as did Koskinen et al
30
, who found that overweight youths without the 250 
metabolic syndrome were 3.9 times more likely to develop T2D in adulthood, 251 
compared to those of with the metabolic syndrome but of normal weight. None of 252 
these studies made statistical adjustments for the effect of adult BMI. 253 
Discussion 254 
This systematic review and meta-analysis indicates that childhood BMI predicts the 255 
risk of prediabetes and CIMT in adulthood. There was a modest predictive effect of 256 
childhood BMI and adult hypertension 257 
The ability of childhood BMI to predict adult ACVD events was weak. This could be 258 
explained by the relatively slow progression of atherosclerosis in healthy young adults
 
259 
or to a later change in environment or habits – for instance the uptake of cigarette 260 
smoking, a significant risk factor, tends to occur no earlier than adolescence 
42
; the 261 
smoking-related formation of focal plaques in coronary vessels is more predictive of 262 
ischemic cardiovascular events than CIMT 
43
. BMI cannot discriminate fat from lean 263 
mass, and the latter has a significant influence CIMT 
44
; this might explain why some 264 
individuals with an abnormal CIMT and high BMI do not develop AVCD 
45
.  265 
Although weight gain in childhood predicted T2D in adulthood, BMI predicted 266 
prediabetes only. BMI is a weaker discriminator of visceral fat than measures such as 267 
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WC and this may impact on the ability of BMI to predict metabolic risk 
46
. Visceral 268 
fat is associated with increased release of free fatty acids (delivered to the liver) and 269 
pro-inflammatory cytokines, which lead to worsening insulin resistance 
47
. T2D 270 
occurs once beta-cell function is no longer able to compensate for this insulin 271 
resistance. Inter-individual differences in beta-cell function and/or mass may 272 
therefore account for the ability of childhood BMI to predict adult prediabetes rather 273 
than T2D. A longer duration of follow-up than that reported in the included studies, 274 
may be required for T2D to develop. 275 
Childhood BMI weakly predicted adult hypertension but did not predict adult systolic 276 
blood pressure.  This may relate to the relatively low tracking of systolic blood 277 
pressure measurements during childhood 
46
.  278 
In most of the included studies, statistical adjustments were not made for the 279 
confounding effect of adult BMI on the risk of ACVD events or dysglycemia 
10
.  In 280 
the studies that did 
32, 35, 40
, there was a partial attenuation in the effect sizes seen, 281 
indicating that adult BMI may have a confounding effect on the outcomes studied. 282 
Also, other potential confounders like ethnicity, socioeconomic status, birth order, 283 
and so forth that were not measured, introduce further bias in the estimated effect 284 
sizes described; less prominent if there is significant correlation between them, more 285 
so otherwise (unmeasured confounders) The weak/modest effect sizes seen in all the 286 
outcomes might also be related to the short length of follow up between childhood 287 
and adulthood (25 years). For instance, the average age at which a man in a 288 
westernized country is diagnosed with an acute coronary event is 65y and just 4-10% 289 
of cases of myocardial infarction occur before the age of 45y 
48. 
A
 
longer duration of 290 
follow-up would mean the accrual of more ACVD and diabetes events.  More events 291 
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may increase the power to determine the effect of childhood anthropometric measures 292 
in predicting adult disease.  293 
The strengths of this systematic review and meta-analysis relate to the wide variety of 294 
anthropometric measures of adiposity studied, and the use of a wide range of outcome 295 
measures. We performed comprehensive searches of multiple databases and ensured 296 
independent study selection and dual data extraction. Although performing a meta-297 
analysis of observational epidemiological studies is often difficult due to incomplete 298 
and unstandardized reporting of studies, the quality of the included studies was good, 299 
and random effect analysis was conducted where significant inter-study variations 300 
was present. Limitations of this review may be that searches were limited to studies 301 
published in English; few studies examined SF and WC and so more studies are 302 
required to confirm the applicability of these measures of adiposity in predicting the 303 
risk of adult ACVD and dysglycemia. Finally, statistical methods like meta-regression 304 
which may be helpful in explaining the cause of heterogeneity, was limited by the 305 
number of studies in each subgroup. 306 
This systematic review found that anthropometric measures of obesity in childhood 307 
predicted CIMT and prediabetes in adulthood. Childhood obesity did not predict 308 
ACVD event rates in adults.  Whether this relates to inherent inaccuracies of the 309 
methods used to measure childhood obesity or to a lack of pathophysiologic effect of 310 
childhood obesity requires further study.  The prevention and reduction of childhood 311 
obesity should remain a priority for public health promotion programs.  312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
 320 
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Table 1. Description of included studies 
Author, yr of publication  Participants Country Type of study Age in childhood a Age 
adulthood a 
N Predictor Outcome  Results                
Cardiovascular disease 
Field, AE. 200527 1963-70 cohort  USA Prospective 11.7 (1.8) 22.1 (1.8) 269 BMI Htn 1unit ↑in BMI=0.5mmHg ↑in SBP in males.          
Hardy, R. 200435 1946 Birth cohort  England Prospective 7 (2-15) 43 1241 BMI Htn/BP Negative correlation but not significant              
Lauer, RM. 198925 Muscatine study USA Prospective      11 (7-18) 26-30 339 BMI Htn/BP In females, R=0.3 for SBP, 0.34 for DBP; in males: 0.29 and 0.14              
Li, L. 200737 1958 Birth cohort England Prospective 11 (7-16) 45 7344 BMI Htn/BP No significant association after adjusting for adult BMI               
Tzoulaki, I. 201033 1966 Birth cohort  Finland Prospective 2 31 3246 PWV Htn/Bp No significant association after adjusting for adult BMI          
Tzoulaki, I. 201033 1966 Birth cohort  Finland Prospective 2 31 3069 PHV Htn/BP r=1.57 P 0.001 after adjusting for adult BMI            
Baker, JL. 200740 1930-76 cohort  Denmark Retrospective  11 (7-13) 25-60 276835 BMI  CVD RR 1.14 in males, 1.10 in females              
Eriksson, JG. 200134 1934-44 cohort Finland Retrospective  11 27-63 4574 BMI  CVD Slight increase in HR 1.03 P 0.0005             
Lawlor, DA. 200536 1950 birth cohort Scotland Retrospective  4.9 (0.7) 36 11106 BMI  CVD  No increase in HR      
Davis, PH. 200126 Muscatine study USA Prospective 8-18 33-42 725 SF CIMT P=0.04 in males, 0.09 in females            
Freedman, DS. 200429 BHS 1959-1968 USA Prospective 11 (3) 35 (3) 513 SF CIMT 1 unit ↑ in SSF=16µm ↑ in CIMT            
Freedman, DS. 200429 BHS 1959-1968  USA Prospective 11 (3) 35 (3) 513 BMI CIMT 1 unit ↑ in BMI=14µm ↑ in CIMT P=0.03 after adjusting for adult BMI            
Davis, PH. 200126 Muscatine study USA Prospective 8-18 33-42 725 BMI CIMT P=0.09 in males, P=0.18 in females            
Freedman, DS. 200928 BHS 1959-1968  USA Prospective 10 (3) 36 (4) 1142 BMI CIMT 1 unit ↑in BMI=16µm ↑in CIMT after adjusting for adult BMI         
Juonala, M. 200631 YFS Finland Prospective 12 (3-18) 33 408 BMI CIMT r=0.05(ns) after adjusting for adult BMI                
Oren, A. 200341 ARYA Netherlands Prospective 12-16 28.4 (1.6) 750 BMI CIMT r=0.9 after adjusting for adult BMI             
Oren, A. 200341 ARYA Netherlands Prospective 12-30 28.4 (1.6) 750 BMI Δ CIMT r 11.8  P 0.01                 
Raitakari, OT. 200332 YFS Finland Prospective 14.9 (2.4) 31.7 (5) 1170 BMI CIMT Small association: r: 0.009, P=0.007                 
Wright, CM. 200138 1947 Birth cohort  England Prospective 9, 13 (9y data) 50 412 BMI CIMT r=-0.02 in women, -0.1 in men after adjusting for adult BMI            
 
Dysglycemia 
Nguyen, QM. 201024 BHS 1981-2000  USA Prospective 11.6 (3.6) 28.3 (5.1) 1120 BMI Δ  IGT OR 1.44 P<0.05 for developing IGT                
Nguyen, QM. 201024 BHS 1981-2000 USA Prospective 11.6 (3.6) 28.3 (5.1) 1120 BMI  IGT OR 1.85 P<0.01 for developing IGT                
Koskinen, J. 201430 YFS Finland Prospective  16.2 (5.3) 32-46 1330 BMI T2D Obesity associated with 3.9 fold increase in risk of T2D            
Nguyen, QM. 201024 BHS 1981-2000  USA Prospective 11.6 (3.6) 28.3 (5.1) 1120 BMI Δ T2D Not predictive                 
Nguyen, QM. 201024 BHS 1981-2000 USA Prospective 11.6 (3.6) 28.3 (5.1) 1120 BMI  T2D Not predictive                 
Fall, CH. 200839 1969-1972 cohort  India Prospective  29.2 (1.3) 1492 BMI Δ  T2D/ IGT OR 1.25 P 0.01 for developing IGT/T2D             
a mean age in years, standard deviation (sd) stated where available, age range stated otherwise. PWV: Peak weight velocity, PHV: peak height velocity, BMI: Body mass index (kg/m2),  
SF: Skin fold thickness; WHR: waist-hip ratio; BP: blood pressure; Htn: Hypertension, defined as systolic ≥140mmHg and/or diastolic ≥90mmHg; IGT and T2D: defined according to ADA criteria  
in 2 studies (14,15) and 1999-WHOcriteria in one study(16). CIMT: carotid intima media thickness; r: regression coefficient; HR: Hazard ratio; OR: Odds ratio; P: Spearman rank correlation;  
ns: P >0.05; N refers to number of participants in adulthood. YFS: Young Finns Study; ARYA: Atherosclerosis Risk in Young Adults study; BHS: Bogalusa Heart Study 
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Table 4. Quality assessment based on the Newcastle-Ottawa Quality Assessment Scale 
Author, yr of publication  Representativea  Data sourceb Adjusts for  
adult measurec 
 Assessment of  
Outcome d 
Follow up e Adequacy  
of follow up f 
Baker, JL. 200740   *	   	   	   *	   *	   *	  
Davis, PH. 200126 *  *   * * * 
Eriksson, JG. 200134   *	   	    *	   *	   *	  
Fall, CH. 200839 *	    *	   	   	   *	    *	  
Field, AE. 200527 	    *	   	    *	   *	   *	  
Freedman, DS. 200429 *	    *	   *(for BMI not SF)	    *	   *	   *	  
Freedman, DS. 200928 *	    *	   *	    *	   *	   *	  
Hardy, R. 200435 *  *	   	    *	   *	   *	  
Juonala, M. 200631 *	    *	   *	    *	   *	   *	  
Koskinen, J. 201430 *	    *	   	   	   *	   *	   *	  
Lauer, RM. 198925 *	    *	   	   	   *	   *	   *	  
Lawlor, DA. 200536 *	    *	   	    *	   *	   *	  
Li, L. 200737 *	    *	   *	    *	   *	   *	  
Nguyen, QM. 201024 *	    *	   	   	   *	   *	   *	  
Oren, A. 200341 *	    *	   *	    *	   *	   *	  
Raitakari, OT. 200332 *	    *	    * 	    *	   *	   *	  
Tzoulaki, I. 201033 *	    *	   *	    *	   *	   	  
Wright, CM. 200138 *	    *	   *	    *	   *	   *	  
a Truly representative or somewhat representative = * rating ; b Secure record linkage = * rating; c Study controls for corresponding adult anthropometric measure = * rating 
d Independent blind or record linkage = * rating; e Was follow up long enough (16 years) for outcomes to occur=* rating; f All subjects accounted for/those lost to follow up unlikely to introduce bias/small number lost 
(<30%)/description provided for those lost = * rating
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